Thomas M. Ross is VP at MAXCYTE, INC. (MXCT). They have made 6 open-market trades across 1 company since 2021, most recently 2024-08-02.
CIK 0001874572
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MXCT | 25,000 | $32K |
Shares reported on the most recent Form 4, priced at the 2024-08-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MXCT | SELL · 10b5-1 | 2024-08-01 | 2024-08-05 | $4.44 | $296K | -5.5% | -10.1% | -13.4% |
| MXCT | SELL · 10b5-1 | 2024-07-08 | 2024-07-10 | $4.03 | $269K | +7.4% | -0.5% | -7.6% |
| MXCT | SELL · 10b5-1 | 2024-06-20 | 2024-06-24 | $4.09 | $273K | -11.8% | +6.0% | -5.0% |
| MXCT | SELL · 10b5-1 | 2023-04-10 | 2023-04-12 | $5.00 | $71K | -3.7% | -26.2% | -2.5% |
| MXCT | SELL · 10b5-1 | 2023-04-05 | 2023-04-07 | $5.03 | $308K | +1.2% | -5.0% | -12.0% |
| MXCT | SELL · 10b5-1 | 2023-03-31 | 2023-04-04 | $5.02 | $50K | +6.9% | -3.5% | -9.0% |
| MXCT | SELL | 2023-02-01 | 2023-02-03 | $5.72 | $333K | -13.9% | -22.6% | -17.0% |
| MXCT | SELL | 2023-01-03 | 2023-01-05 | $5.09 | $202K | +5.8% | +7.5% | -1.6% |
| MXCT | SELL | 2022-12-02 | 2022-12-06 | $5.74 | $248K | -0.2% | -4.9% | -17.6% |
| MXCT | SELL | 2022-11-01 | 2022-11-03 | $6.93 | $364K | +1.8% | -19.2% | -15.3% |
| MXCT | SELL | 2022-10-10 | 2022-10-12 | $6.45 | $348K | +4.8% | +17.7% | -12.4% |
| MXCT | SELL | 2021-11-12 | 2021-11-16 | $12.31 | $3.1M | -30.6% | -24.4% | -48.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.